Ambient Clinical Analytics’ flagship product is the AWARE™ platform, an FDA Class II–cleared system built on clinically validated algorithms and technology licensed from the Mayo Clinic. The platform delivers real-time clinical analytics and clinical decision support across bedside care, command centers, and remote monitoring environments. A primary use case highlighted is improving protocol adherence for sepsis care, a time-sensitive and complex workflow. The company plans to use the newly raised capital to accelerate product innovation, expand platform adoption across health systems, and deepen strategic partnerships in high-acuity settings. Leadership changes include the appointment of Brian Tufts as CEO while founder Al Berning moves to Executive Chairman. The articles did not provide operating metrics such as revenue or user counts.

Total raised

$5M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2026